Virus Spread in the Liver: mechanisms, commonalities, and Unanswered Questions

References

• Treyer A , MuschA. Hepatocyte polarity. Compr. Physiol., 3(1), 243–287 (2013).
   PubMed Web of Science ®Google Scholar
• Cox AL , El-SayedMH, KaoJHet al. Progress towards elimination goals for viral hepatitis. Nat. Rev. Gastroenterol. Hepatol., 17(9), 533–542 (2020).
   PubMed Web of Science ®Google Scholar
• Lanini S , UstianowskiA, PisapiaR, ZumlaA, IppolitoG. Viral hepatitis: etiology, epidemiology, transmission, diagnostics, treatment, and prevention. Infect. Dis. Clin. North Am., 33(4), 1045–1062 (2019).
   PubMedGoogle Scholar
• Mcknight KL , LemonSM. Hepatitis A virus genome organization and replication strategy. Cold Spring Harb. Perspect. Med., 8(12), a033480 (2018).
   PubMedGoogle Scholar
• Kenney SP , MengXJ. Cold Spring Harb. Perspect. Med., 9(1), a031724 (2019).
   PubMedGoogle Scholar
• Lucifora J , DelphinM. Current knowledge on hepatitis delta virus replication. Antiviral Res. doi:10.1016/j.antiviral.2020.104812104812 (2020). ( Epub ahead of print).
   PubMedGoogle Scholar
• Dubuisson J , CossetFL. Virology and cell biology of the hepatitis C virus life cycle: an update. J. Hepatol., 61(Suppl. 1), S3–S13 (2014).
   PubMed Web of Science ®Google Scholar
• Seeger C , MasonWS. Molecular biology of hepatitis B virus infection. Virology, 479–480, 672–686 (2015).
   PubMed Web of Science ®Google Scholar
• Feng Z , HensleyL, McknightKLet al. A pathogenic picornavirus acquires an envelope by hijacking cellular membranes. Nature, 496(7445), 367–371 (2013).
   PubMed Web of Science ®Google Scholar
• Takahashi M , YamadaK, HoshinoYet al. Monoclonal antibodies raised against the ORF3 protein of hepatitis E virus (HEV) can capture HEV particles in culture supernatant and serum but not those in feces. Arch. Virol., 153(9), 1703–1713 (2008).
   PubMed Web of Science ®Google Scholar
• Feng Z , LemonSM. Peek-a-boo: membrane hijacking and the pathogenesis of viral hepatitis. Trends Microbiol., 22(2), 59–64 (2014).
   PubMed Web of Science ®Google Scholar
• Raposo G , StoorvogelW. Extracellular vesicles: exosomes, microvesicles, and friends. J. Cell Biol., 200(4), 373–383 (2013).
   PubMed Web of Science ®Google Scholar
• Hurley JH . The ESCRT complexes. Crit. Rev. Biochem. Mol. Biol., 45(6), 463–487 (2010).
   PubMed Web of Science ®Google Scholar
• Jiang W , MaP, DengLet al. Hepatitis A virus structural protein pX interacts with ALIX and promotes the secretion of virions and foreign proteins through exosome-like vesicles. J. Extracell. Vesicles, 9(1), 1716513 (2020).
   PubMed Web of Science ®Google Scholar
• Nagashima S , TakahashiM, JirintaiSet al. A PSAP motif in the ORF3 protein of hepatitis E virus is necessary for virion release from infected cells. J. Gen. Virol., 92(Pt 2), 269–278 (2011).
   PubMedGoogle Scholar
• Nagashima S , TakahashiM, JirintaiSet al. Tumour susceptibility gene 101 and the vacuolar protein sorting pathway are required for the release of hepatitis E virions. J. Gen. Virol., 92(Pt 12), 2838–2848 (2011).
   PubMedGoogle Scholar
• Yamada K , TakahashiM, HoshinoYet al. ORF3 protein of hepatitis E virus is essential for virion release from infected cells. J. Gen. Virol., 90(Pt 8), 1880–1891 (2009).
   PubMed Web of Science ®Google Scholar
• Gouttenoire J , PollanA, AbramiLet al. Palmitoylation mediates membrane association of hepatitis E virus ORF3 protein and is required for infectious particle secretion. PLoS Pathog., 14(12), e1007471 (2018).
   PubMed Web of Science ®Google Scholar
• Ding Q , HellerB, CapuccinoJMet al. Hepatitis E virus ORF3 is a functional ion channel required for release of infectious particles. Proc. Natl Acad. Sci. USA, 114(5), 1147–1152 (2017).
   PubMed Web of Science ®Google Scholar
• Takahashi M , TanakaT, TakahashiHet al. Hepatitis E virus (HEV) strains in serum samples can replicate efficiently in cultured cells despite the coexistence of HEV antibodies: characterization of HEV virions in blood circulation. J. Clin. Microbiol., 48(4), 1112–1125 (2010).
   PubMed Web of Science ®Google Scholar
• Yin X , AmbardekarC, LuY, FengZ. Distinct entry mechanisms for nonenveloped and quasi-enveloped hepatitis E viruses. J. Virol., 90(8), 4232–4242 (2016).
   PubMedGoogle Scholar
• Yin X , FengZ. Hepatitis E virus entry. Viruses, 11(10), 883 (2019).
   PubMedGoogle Scholar
• Rivera-Serrano EE , Gonzalez-LopezO, DasA, LemonSM. Cellular entry and uncoating of naked and quasi-enveloped human hepatoviruses. Elife, 8, e43983 (2019).
   PubMed Web of Science ®Google Scholar
• Sayed IM , VerhoyeL, CocquerelLet al. Study of hepatitis E virus infection of genotype 1 and 3 in mice with humanised liver. Gut, 66(5), 920–929 (2017).
   PubMed Web of Science ®Google Scholar
• Allweiss L , GassS, GierschKet al. Human liver chimeric mice as a new model of chronic hepatitis E virus infection and preclinical drug evaluation. J. Hepatol., 64(5), 1033–1040 (2016).
   PubMed Web of Science ®Google Scholar
• Asher LV , BinnLN, MensingTL, MarchwickiRH, VassellRA, YoungGD. Pathogenesis of hepatitis A in orally inoculated owl monkeys (Aotus trivirgatus). J. Med. Virol., 47(3), 260–268 (1995).
   PubMedGoogle Scholar
• Victor JC , MontoAS, SurdinaTYet al. Hepatitis A vaccine versus immune globulin for postexposure prophylaxis. N. Eng. J. Med., 357(17), 1685–1694 (2007).
   PubMed Web of Science ®Google Scholar
• Hu J , ProtzerU, SiddiquiA. Revisiting hepatitis B virus: challenges of curative therapies. J. Virol., 93(20), (2019).
   Google Scholar
• Prange R . Host factors involved in hepatitis B virus maturation, assembly, and egress. Med. Microbiol. Immunol., 201(4), 449–461 (2012).
   PubMed Web of Science ®Google Scholar
• Hu J , LiuK. Complete and incomplete hepatitis B virus particles: formation, function, and application. Viruses, 9(3), (2017).
   Web of Science ®Google Scholar
• Schulze A , GriponP, UrbanS. Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans. Hepatology, 46(6), 1759–1768 (2007).
   PubMed Web of Science ®Google Scholar
• Yan H , ZhongG, XuGet al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Elife, 1, e00049 (2012).
   PubMed Web of Science ®Google Scholar
• Iwamoto M , SasoW, SugiyamaRet al. Epidermal growth factor receptor is a host–entry cofactor triggering hepatitis B virus internalization. Proc. Natl Acad. Sci. USA, 116(17), 8487–8492 (2019).
   PubMed Web of Science ®Google Scholar
• Herrscher C , PastorF, Burlaud-GaillardJet al. Hepatitis B virus entry into HepG2-NTCP cells requires clathrin-mediated endocytosis. Cell Microbiol., 22(8), e13205 (2020).
   PubMed Web of Science ®Google Scholar
• Sureau C , NegroF. The hepatitis delta virus: Replication and pathogenesis. J. Hepatol., 64(Suppl. 1), S102–S116 (2016).
   PubMedGoogle Scholar
• Tu T , UrbanS. Virus entry and its inhibition to prevent and treat hepatitis B and hepatitis D virus infections. Curr. Opin. Virol., 30, 68–79 (2018).
   PubMedGoogle Scholar
• Li W , UrbanS. Entry of hepatitis B and hepatitis D virus into hepatocytes: Basic insights and clinical implications. J. Hepatol., 64(Suppl. 1), S32–S40 (2016).
   PubMedGoogle Scholar
• Blondot ML , BrussV, KannM. Intracellular transport and egress of hepatitis B virus. J. Hepatol., 64(Suppl. 1), S49–S59 (2016).
   PubMedGoogle Scholar
• Winer BY , Shirvani-DastgerdiE, BramYet al. Preclinical assessment of antiviral combination therapy in a genetically humanized mouse model for hepatitis delta virus infection. Sci. Transl. Med., 10(447), (2018).
   PubMedGoogle Scholar
• Perez-Vargas J , AmiracheF, BosonBet al. Enveloped viruses distinct from HBV induce dissemination of hepatitis D virus in vivo. Nat. Commun., 10(1), 2098 (2019).
   PubMedGoogle Scholar
• Scheel TK , RiceCM. Understanding the hepatitis C virus life cycle paves the way for highly effective therapies. Nat. Med., 19(7), 837–849 (2013).
   PubMed Web of Science ®Google Scholar
• Wakita T , PietschmannT, KatoTet al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med., 11(7), 791–796 (2005).
   PubMed Web of Science ®Google Scholar
• Lindenbach BD , EvansMJ, SyderAJet al. Complete replication of hepatitis C virus in cell culture. Science, 309(5734), 623–626 (2005).
   PubMed Web of Science ®Google Scholar
• Zhong J , GastaminzaP, ChengGet al. Robust hepatitis C virus infection in vitro. Proc. Natl Acad. Sci. USA, 102(26), 9294–9299 (2005).
   PubMed Web of Science ®Google Scholar
• Coller KE , HeatonNS, BergerKL, CooperJD, SaundersJL, RandallG. Molecular determinants and dynamics of hepatitis C virus secretion. PLoS Pathog., 8(1), e1002466 (2012).
   PubMed Web of Science ®Google Scholar
• Gerold G , MoellerR, PietschmannT. Hepatitis C virus entry: protein interactions and fusion determinants governing productive hepatocyte invasion. Cold Spring Harb. Perspect. Med., 10(2), a036830 (2020).
   PubMedGoogle Scholar
• Catanese MT , UryuK, KoppMet al. Ultrastructural analysis of hepatitis C virus particles. Proc. Natl Acad. Sci. USA, 110(23), 9505–9510 (2013).
   PubMed Web of Science ®Google Scholar
• Chang KS , JiangJ, CaiZ, LuoG. Human apolipoprotein e is required for infectivity and production of hepatitis C virus in cell culture. J. Virol., 81(24), 13783–13793 (2007).
   PubMed Web of Science ®Google Scholar
• Jones DM , MclauchlanJ. Hepatitis C virus: assembly and release of virus particles. The J. Biol. Chem., 285(30), 22733–22739 (2010).
   PubMedGoogle Scholar
• Fukuhara T , OnoC, Puig-BasagoitiF, MatsuuraY. Roles of lipoproteins and apolipoproteins in particle formation of hepatitis C virus. Trends Microbiol., 23(10), 618–629 (2015).
   PubMedGoogle Scholar
• Belouzard S , DanneelsA, FeneantL, SeronK, RouilleY, DubuissonJ. Entry and release of hepatitis C virus in polarized human hepatocytes. J. Virol., 91(18), e00478–17 (2017).
   PubMedGoogle Scholar
• Graw F , PerelsonAS. Modeling Viral Spread. Annu. Rev. Virol., 3(1), 555–572 (2016).
   PubMedGoogle Scholar
• Baktash Y , MadhavA, CollerKE, RandallG. Single particle imaging of polarized hepatoma organoids upon hepatitis C virus infection reveals an ordered and sequential entry process. Cell Host Microb., 23(3), 382–394e385 (2018).
   PubMedGoogle Scholar
• Miao Z , XieZ, MiaoJ, RanJ, FengY, XiaX. Regulated entry of hepatitis C virus into hepatocytes. Viruses, 9(5), 100 (2017).
   PubMed Web of Science ®Google Scholar
• Longatti A , BoydB, ChisariFV. Virion-independent transfer of replication-competent hepatitis C virus RNA between permissive cells. J. Virol., 89(5), 2956–2961 (2015).
   PubMedGoogle Scholar
• Bukong TN , Momen-HeraviF, KodysK, BalaS, SzaboG. Exosomes from hepatitis C infected patients transmit HCV infection and contain replication competent viral RNA in complex with Ago2-miR122-HSP90. PLoS Pathog., 10(10), e1004424 (2014).
   PubMed Web of Science ®Google Scholar
• Pinto RM , AragonesL, CostafredaMI, RibesE, BoschA. Codon usage and replicative strategies of hepatitis A virus. Virus Res., 127(2), 158–163 (2007).
   PubMedGoogle Scholar
• Kelly AG , NetzlerNE, WhitePA. Ancient recombination events and the origins of hepatitis E virus. BMC Evol. Biol., 16(1), 210 (2016).
   PubMedGoogle Scholar
• Yin X , YingD, LhommeSet al. Origin, antigenicity, and function of a secreted form of ORF2 in hepatitis E virus infection. Proc. Natl Acad. Sci. USA, 115(18), 4773–4778 (2018).
   PubMed Web of Science ®Google Scholar
• Ding S , SongY, BruloisKFet al. Retinoic acid and lymphotoxin signaling promote differentiation of human intestinal M cells. Gastroenterology, 159(1), 214–226. e1 (2020).
   PubMedGoogle Scholar
• Ettayebi K , CrawfordSE, MurakamiKet al. Replication of human noroviruses in stem cell-derived human enteroids. Science, 353(6306), 1387–1393 (2016).
   PubMed Web of Science ®Google Scholar
• Webb GW , DaltonHR. Hepatitis E: an underestimated emerging threat. Ther. Adv. Infect. Dis., 6, doi:10.1177/2049936119837162 (2019).
   PubMedGoogle Scholar
• Kamar N , PischkeS. Acute and persistent hepatitis E virus genotype 3 and 4 Infection: clinical features, pathogenesis, and treatment. Cold Spring Harb. Perspect. Med., 9(7), a031872 (2019).
   PubMedGoogle Scholar
• Feng Z . Causation by HEV of extrahepatic manifestations remains unproven. Liver Int., 36(4), 477–479 (2016).
   PubMedGoogle Scholar
• Wieland S , MakowskaZ, CampanaBet al. Simultaneous detection of hepatitis C virus and interferon stimulated gene expression in infected human liver. Hepatology, 59(6), 2121–2130 (2014).
   PubMed Web of Science ®Google Scholar
• Neumann AU , LamNP, DahariHet al. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science, 282(5386), 103–107 (1998).
   PubMed Web of Science ®Google Scholar
• Li J , LiuK, LiuYet al. Exosomes mediate the cell-to-cell transmission of IFN-α-induced antiviral activity. Nat. Immunol., 14(8), 793–803 (2013).
   PubMed Web of Science ®Google Scholar